Internal Medicine Alert
RSSArticles
-
Wheat Causes Intestinal Immune Activation in Some Patients Without Celiac Disease
Some patients without celiac disease may exhibit wheat sensitivity with demonstrated intestinal epithelial cell damage.
-
Too Little of a Good Thing Can Be a Bad Thing
A healthy lifestyle may substantially reduce the burden of cancer.
-
Wide Rhythm in a Patient with Chest Pain
-
Clinical Briefs
In this section: A new statin toxicity emerges; debates about diabetes screening continues; and exploring links between chronic fatigue and serious outcomes.
-
Obeticholic Acid Tablets (Ocaliva)
Obeticholic acid provides an FDA-approved treatment option for patients who have not responded adequately to or are unable to tolerate ursodeoxycholic acid.
-
Combination of Simvastatin Plus Vitamin D Offers New Hope for Migraine Prevention
Recent study shows the combination of simvastatin plus vitamin D3 is effective in the prevention of headaches in adults with episodic migraine.
-
Preventing 90% of Stroke with 10 Modifiable Risk Factors
Controlling 10 modifiable risk factors would prevent 90.7% of strokes, according to results from a 32-country study.
-
Reducing Cardiovascular Events in Older Adults Through Blood Pressure Control
Among ambulatory adults ≥ 75 years of age, treating to a systolic blood pressure (SBP) target of < 120 mmHg compared with an SBP target of < 140 mmHg resulted in a significantly lower rate of fatal and nonfatal major cardiovascular events and death from any cause.
-
Clinical Briefs
In this section:
-
Sofosbuvir and Velpatasvir Tablets (Epclusa)
Sofosbuvir and velpatasvir tablets are indicated for the treatment of adult patients with chronic HCV genotype 1, 2, 3, 4, 5, or 6 infections.